Rivastigmine for Intensive Care Unit (ICU) Delirium
Status:
Terminated
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
Delirium in Intensive Care (IC) patients is a frequent disorder. The aim of this study is to
investigate whether treatment of delirium in the ICU with rivastigmine added to haloperidol
shortens the duration of delirium in comparison to placebo added to the treatment with
haloperidol.
Phase:
Phase 4
Details
Lead Sponsor:
UMC Utrecht
Collaborators:
Hersenstichting Netherlands Brain Foundation Novartis ZonMw: The Netherlands Organisation for Health Research and Development